The NOBEL Project builds a unique ecosystem in EUROPE for the convergence of Nanomedicine & emerging medical technologies. NOBEL is a Coordination and Support Action (C.S.A.) funded for three years by the European Union's Horizon 2020 research and innovation programme under the grant agreement no .766492. VISION From precision engineering to smart connected Healthtech, NOBEL is paving the way for the new ESTHER Healthtech value chain, supporting translation of innovative concepts into healthcare solutions. CONSORTIUM NOBEL is an EU funded H2020 project coordinated by the European Technology Platform on Nanomedicine (ETPN). The consortium also includes the CEA, MedTech Europe, Bioanalytik Muenster, VDI/VDE/IT, TecMinho, Fondazione Don Gnocchi, Tyndall National Institute, and Nanobiotix (as a third party).Their action will be supported and amplified by a network of associated partners, including national platforms and other ETPs. MISSIONS ✓align & integrate separate strategies and roadmaps into a single roadmap for the future of medical technologies in Europe ✓create a functional and sustainable ecosystem for EU emerging medical technologies ✓improve awareness and communication among all healthcare stakeholders in Europe ✓provide Translation & Acceleration tools for innovative projects in HealthTech, expanding the successful concept of the Nanomedicine Translation HUB designed by the ETPN IMPACT ✓Increased take-up of innovative nanomedicine and emerging medical technologies solutions by industry and SMEs, end-users, regulatory and public authorities, healthcare insurances, doctors and patients, research organisations and academia ✓Improvement of cross-KETs activities to provide better integrated smart healthcare solutions ✓Increased international networking with new potential market opportunities Global Improvement of the competitiveness of the European healthcare sector